BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kadokawa Y, Omagari K, Ohba K, Masuda J, Hazama H, Kinoshita H, Ohnita K, Mizuta Y, Tanioka H, Imanishi T. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease? Liver Int. 2005;25:317-324. [PMID: 15780056 DOI: 10.1111/j.1478-3231.2005.01078.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Bargou I, Mankaï A, Jamaa A, Ben Jazia I, Skandrani K, Sfar H, Baccouche A, Ajmi S, Letaief A, Fabien N, Jeddi M, Ghedira I. Detection of M2 antimitochondrial antibodies by dot blot assay is more specific than by enzyme linked immunosorbent assay. Pathologie Biologie 2008;56:10-4. [DOI: 10.1016/j.patbio.2007.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
2 Omagari K, Hazama H, Kohno S. Enzyme inhibition assay for pyruvate dehydrogenase complex: Clinical utility for the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2005; 11(43): 6735-6739 [PMID: 16425376 DOI: 10.3748/wjg.v11.i43.6735] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
3 Hirschfield GM, Heathcote EJ. Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis. 2008;12:323-331; viii-ix. [PMID: 18456183 DOI: 10.1016/j.cld.2008.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
4 Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, de Faria Gomes NM, Oliveira EMG, Rotman V, Oliveira MB, da Cunha SMCF, Cunha-Silva M, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, de Lima Pace FH, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA; Members of the Brazilian Cholestasis Study Group Consortium. Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis. Dig Dis Sci 2021. [PMID: 34181166 DOI: 10.1007/s10620-021-07122-y] [Reference Citation Analysis]
5 Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Lee PC, Lee SD, Wu JC. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int. 2008;28:1305-1313. [PMID: 18346129 DOI: 10.1111/j.1478-3231.2008.01715.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
6 Petrogiannopoulos C, Papamichael K, Karachalios G, Karachaliou I, Kostakos N, Barbati K, Zacharof A. Autoimmune cholangitis presented as fever of unknown origin. Chemotherapy 2006;52:282-4. [PMID: 17008778 DOI: 10.1159/000095958] [Reference Citation Analysis]
7 Chen S, Zhu GJ, Deng GH, Zhu Y. Clinical pathology and HLA-DRB1 allele associations of primary biliary cirrhosis and autoimmune cholangitis in Han Chinese. Shijie Huaren Xiaohua Zazhi 2005; 13(20): 2450-2454 [DOI: 10.11569/wcjd.v13.i20.2450] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Chascsa DMH, Lindor KD. Emerging therapies for PBC. J Gastroenterol 2020;55:261-72. [PMID: 31970467 DOI: 10.1007/s00535-020-01664-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Chascsa DM, Lindor KD. Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease? Clin Liver Dis. 2018;22:589-601. [PMID: 30259855 DOI: 10.1016/j.cld.2018.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]